ANI PHARMACEUTICALS INC

By person

16 insiders · 48 transactions

28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lalwani Nikhil

PRESIDENT & CEO

—

$5.05M (3)

−$5.05M

339,089

1.51%

$24.08M

−9.3%

Walsh Patrick D

Director

—

$2.32M (4)

−$2.32M

38,432

0.1709%

$2.73M

−48.6%

CAREY STEPHEN P.

SVP & CFO

—

$1.78M (7) scheduled

−$1.78M

171,843

0.7640%

$12.20M

+6.1%

Mutz Christopher

HEAD OF RARE DISEASE

—

$1.64M (6) scheduled

−$1.64M

91,309

0.4060%

$6.48M

+9.6%

Gassert Chad

SVP - CORP. DEV. & STRATEGY

—

$1.31M (2)

−$1.31M

233,406

1.04%

$16.57M

−3.9%

Davis Krista

SVP, CHIEF HR OFFICER

—

$1.02M (6) scheduled

−$1.02M

51,946

0.2310%

$3.69M

+3.8%

Gutwerg Ori

SVP, GENERICS

—

$621.44K (3)

−$621.44K

75,534

0.3358%

$5.36M

−2.2%

Cook Meredith

SR. VP, GENERAL COUNSEL & SEC.

—

$453.87K (12) scheduled

−$453.87K

73,924

0.3287%

$5.25M

+30.3%

Rowland Thomas Andrew

SVP, HEAD - ESTABLISHED BRANDS

—

$393.83K (2)

−$393.83K

38,271

0.1702%

$2.72M

+9.6%

HAUGHEY THOMAS

Director

—

$161.76K (1) scheduled

−$161.76K

38,878

0.1729%

$2.76M

−24.5%

TANNENBAUM RENEE P

Director

—

$146.07K (1)

−$146.07K

29,514

0.1312%

$2.10M

+30.5%

Thoma Jeanne

Director

—

$71.53K (1) scheduled

−$71.53K

26,762

0.1190%

$1.90M

−34.1%

Shanmugam Muthusamy

HEAD OF R&D, COO-NOVITIUM OPS

—

532,976

2.37%

$37.84M

−24.0%

Pera Antonio R

Director

—

27,017

0.1201%

$1.92M

−13.0%

Leonard Matthew J

Director

—

11,221

0.0499%

$796.69K

−6.4%

Gosebruch Henry O

Director

—

6,662

0.0296%

$473.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Lalwani Nikhil

15 Sep 2026

PRESIDENT & CEO

Sold on a plan

5,400

$71.00

$383.40K

Cook Meredith

14 Sep 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$70.79

$35.40K

Thoma Jeanne

11 Sep 2026

Director

Sold on a plan

1,000

$71.53

$71.53K

CAREY STEPHEN P.

31 Aug 2026

SVP & CFO

Sold on a plan

2,850

$72.80

$207.48K

Lalwani Nikhil

25 Aug 2026

PRESIDENT & CEO

Sold on a plan

5,400

$74.30

$401.22K

Cook Meredith

13 Aug 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$75.48

$37.74K

CAREY STEPHEN P.

29 Jul 2026

SVP & CFO

Sold on a plan

2,850

$81.36

$231.88K

Cook Meredith

13 Jul 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$81.84

$40.92K

CAREY STEPHEN P.

29 Jun 2026

SVP & CFO

Sold on a plan

2,850

$84.12

$239.74K

Cook Meredith

12 Jun 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$82.03

$41.02K

HAUGHEY THOMAS

8 Jun 2026

Director

Sold on a plan

2,000

$80.88

$161.76K

Cook Meredith

13 May 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$78.16

$39.08K

Cook Meredith

13 Apr 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$77.95

$38.98K

Cook Meredith

13 Mar 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$72.62

$36.31K

Mutz Christopher

13 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

3,162

$71.64

$226.53K

Davis Krista

9 Mar 2026

SVP, CHIEF HR OFFICER

Sold on a plan

5,087

$74.13

$377.10K

Mutz Christopher

9 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

3,602

$74.18

$267.20K

Davis Krista

6 Mar 2026

SVP, CHIEF HR OFFICER

Sold on a plan

1,485

$75.00

$111.38K

Mutz Christopher

6 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

2,121

$74.22

$157.42K

Mutz Christopher

2 Mar 2026

HEAD OF RARE DISEASE

Sold on a plan

417

$74.00

$30.86K

Davis Krista

20 Feb 2026

SVP, CHIEF HR OFFICER

Sold on a plan

1,730

$77.99

$134.92K

Mutz Christopher

20 Feb 2026

HEAD OF RARE DISEASE

Sold on a plan

5,323

$78.02

$415.30K

Davis Krista

19 Feb 2026

SVP, CHIEF HR OFFICER

Sold on a plan

2,084

$77.53

$161.57K

Cook Meredith

13 Feb 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$76.80

$38.40K

Mutz Christopher

12 Feb 2026

HEAD OF RARE DISEASE

Sold on a plan

7,032

$76.55

$538.30K

Cook Meredith

13 Jan 2026

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

500

$84.33

$42.17K

Davis Krista

18 Dec 2025

SVP, CHIEF HR OFFICER

Sold on a plan

1,622

$82.40

$133.65K

Cook Meredith

12 Dec 2025

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

400

$82.32

$32.93K

Cook Meredith

13 Nov 2025

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

400

$87.27

$34.91K

Cook Meredith

13 Oct 2025

SR. VP, GENERAL COUNSEL & SEC.

Sold on a plan

400

$90.09

$36.04K

Davis Krista

19 Sep 2025

SVP, CHIEF HR OFFICER

Sold on a plan

1,000

$98.04

$98.04K

Show all 48 transactions →

By person

Individual transactions

What was left out